AA
MRNA icon

Advisory Alpha’s Moderna MRNA Stock Holding History

Advisory Alpha’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,399
Closed -$227K – 449
2024
Q3 		$227K Sell
3,399
-257
-7% -$23.6K 0.01% 378
2024
Q2 		$434K Sell
3,656
-43
-1% -$5.44K 0.02% 234
2024
Q1 		$394K Buy
+3,699
New +$373K 0.02% 247
2020
Q4 		– Sell
-86
Closed -$6K – 441
2020
Q3 		$6K Buy
+86
New +$6K ﹤0.01% 496

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Advisory Alpha's MRNA Position: Q4 2024 in Review

Advisory Alpha sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,399 shares — an estimated $227K sold.

Advisory Alpha first reported a position in MRNA in Q3 2020 and held it in 4 quarters. The position peaked at $434K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Advisory Alpha reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Advisory Alpha sold 3,399 Moderna shares in Q4 2024, an estimated $227K.
  • Advisory Alpha first reported a position in Moderna in Q3 2020 and held it in 4 quarters.
  • Advisory Alpha's Moderna position peaked at $434K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Advisory Alpha's 13F filing for Q4 2024, filed 17 Jan 2025.